SA News • Nov. 22, 2013
Be smarter and faster with PRO Alerts on SGIOF
From other sites
There are no Focus articles on SGIOF.
There are no Transcripts on SGIOF.
Nov. 22, 2013, 12:00 PM
Mar. 25, 2013, 6:20 AMAstraZeneca (AZN) and partner Shionogi (SGIOF.PK) have received a boost after Actavis (ACT) unit Watson Laboratories and Egis agreed to drop their attempts to introduce generic versions of AstraZeneca's blockbuster cholesterol drug Crestor until May 2016. The settlement comes after a court upheld the patent on the treatment in December. | Comment!
Jul. 11, 2012, 4:42 AM
Sep. 1, 2008, 11:22 AM
We currently have no instablog posts on this stock.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
SGIOF vs. ETF Alternatives
Other News & PR